Adent and Khiron Announce Closing of Subscription Receipt Financing
16 janv. 2018 11h53 HE
|
Khiron Life Sciences Corp.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Further to the press releases dated November 7, 2017, and...
Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation of Medical Cannabis Strains
28 déc. 2017 09h23 HE
|
Khiron Life Sciences Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the...
Khiron Provides Corporate Update & Revises Financing Terms
14 déc. 2017 08h42 HE
|
Khiron Life Sciences Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) is pleased to...
Khiron and Adent Announce Letter of Intent for Proposed Business Combination
26 oct. 2017 17h12 HE
|
Khiron Life Sciences Corp.
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron”) and Adent Capital Corp. ("Adent") (NEX:ANT.H) report that the parties have entered into an arm’s length non-binding...
Khiron First Company to be Fully Licensed for High and Low THC Medical Cannabis in Colombia
23 oct. 2017 15h48 HE
|
Khiron Life Sciences Corp.
TORONTO, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that further to its press release dated September 26, 2017, the Company’s wholly owned...
Khiron Advisor Featured as Part of Joint Investigation by 60 Minutes and the Washington Post on U.S. Opioid Crisis
13 oct. 2017 18h45 HE
|
Khiron Life Sciences Corp.
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that Matthew Murphy, Security and Compliance Advisor to Khiron, and former U.S. DEA Chief of...
Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board
29 sept. 2017 11h08 HE
|
Khiron Life Sciences Corp.
TORONTO, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration...
Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia
26 sept. 2017 09h07 HE
|
Khiron Life Sciences Corp.
TORONTO, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence...